Skip to main content Accessibility help
×
Home

Does Propranolol have an Antipsychotic Effect?: A Placebo-Controlled Study in Acute Schizophrenia

  • Rahul Manchanda (a1) and Steven R. Hirsch (a2)

Abstract

Thirty-six acute schizophrenics were randomly assigned to dextro (d)-propranolol or placebo in a double blind trial lasting four weeks. All patients had a fixed dose of haloperidol during the first week, which resulted in an initial improvement in both groups. Thereafter, a deterioration towards base-line was seen. Six patients on placebo, but none on propranolol were treatment failures at the end of three weeks (P < 0.001). Comparison of change in scores from week 2 to 4 showed significantly greater deterioration in the placebo group; d-propranolol thus had a better effect than placebo in sustaining the initial improvement with haloperidol. The overall magnitude of clinical change from pre-treatment scores is small, the majority of the patients showing little or no overall improvement. It is concluded that d-propranolol has a detectable therapeutic effect, which by inference must have a novel pharmacological basis, but this is not as potent as standard neuroleptics.

Copyright

Corresponding author

Correspondence.

References

Hide All
Åsberg, M., Montgomery, S. A., Perris, C., Schalung, D. & Sedvall, G. (1978) The comprehensive psychopathological rating scale. Acta Psychiatrica Scandinavica Supplement, 271, 527.
Atsmon, A. & Blum, J. (1970) Treatment of acute porphyria variegata with propranolol. Lancet, i, 196197.
Atsmon, A., Blum, I., Wusenbeck, H., Maoz, B., Steiner, M. & Ztegelman, G. (1971) The short term effects of adrenergic blocking agents in a small group of psychotic patients. Preliminary clinical observations. Psychiatria, Neurologica, Neurochirurgia. 74, 251258.
Creese, I., Burt, D. R. & Snyder, S. H. (1978) Neuroleptics and schizophrenia. In Handbook of Psychopharmacology. Vol. 10 (eds.) Iverson, L. L., Iverson, S. D. & Snyder, S. H., New York: Plenum.
Davis, J. M. & Garver, D. L. (1978) Neuroleptics: clinical use in psychiatry. In Handbook of Psychopharmacology, Vol. 10 (eds). Iverson, L. L., New York: Plenum.
Emrich, H. M., Zerssen, D. V., Moller, H. J., Kissling, W., Cording, C., Schtetsch, E. & Riedel, J. (1979) Action of propranol in mania: comparison of effects of the d- and the 1-stereoisomer. Pharmakopsychiatry and Neuropsychopharmacology, 12, 295304.
Green, A. R. & Grahame-Smith, D. G. (1976) Propranolol inhibits the behavioural responses of rats to increase 5HT in the central nervous system. Nature, 262, 594596.
Gruzelier, J. H., Hirsch, S. R., Weller, M. P. I. & Murphy, C. (1979) Influence of d- or dl-propranolol and chlorpramzine on habituation of phasic electrodermal responses in schizophrenia. Acta Psychiatrica Scandinavica, 60, 241248.
Hanssen, T., Heyden, T., Sundberg, I., Alfredsson, G., Nyback, H. & Wetterberg, L. (1980) Propranolol in Schizophrenia: clinical, metabolic and pharmacological findings. Archives of General Psychiatry, 37, 685690.
Hirsch, S. R., Manchanda, R. & Weller, M. P. I. (1980) Dextro-propranolol in schizophrenia. Progress in Neuro-Psychopharmacology, 4, 633637.
Honigfeld, G. & Klett, C. (1965) The nurses observation scale for inpatient evaluation (NOSIE): a new scale for measuring improvement in chronic schizophrenia. Journal of Clinical Psychology, 21, 6571.
King, D. J., Turkson, S. M., Liddle, J. & Kinney, C. D. (1980) Some clinical and metabolic aspects of propranolol in chronic schizophrenia. British Journal of Psychiatry, 137, 458468.
Krawiecka, M., Goldberg, D. & Vaughan, M. (1977) A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatrica Scandinavica, 55, 299308.
Lindstrom, L. H. & Persson, E. (1980) Propranolol in chronic schizophrenia: a controlled study in neuroleptic treated patients. British Journal of Psychiatry, 137, 126130.
Manchanda, R. & Hirsch, S. R. (1981) (Des-Tyr1)-endorphin in the treatment of schizophrenia. Psychological Medicine, 11, 401404.
Manchanda, R. & Hirsch, S. R. (1986) Rating scales for clinical studies in schizophrenia. In The Pharmacology and Drug Treatment of Schizophrenia. Oxford University Press.
Moller, H. J., Zerssen, D. V., Emrich, H. M., Kissung, W., Cording, C., Schtetsch, H. J. & Riedel, E. (1979) Action of d-propranolol in manic psychoses. Archives of Psychiatry and Neurological Sciences, 227, 301317.
Myers, D. H., Campbell, P. L., Cocks, N. M., Flowerdew, J. A. Mum, A. (1981) A trial of propranolol in chronic schizophrenia. British Journal of Psychiatry, 139, 118121, 1981.
Overall, J. E. & Gorham, D. R. (1962) The brief psychiatric rating scale. Psychological Reports, 10, 799812.
Peet, M., Bethell, M. S., Coates, A., Khamnee, A. K., Hall, P., Cooper, S. J., King, D. J. & Yates, R. A. (1981a) Propranolol in schizophrenia: comparison of propranolol, chlorpromazine and placebo. British Journal of Psychiatry, 139, 105111.
Hall, P., Middlemiss, D. N. & Yates, R. A. (1981b) Propranolol in schizophrenia: clinical and biochemical aspects of combining propranolol with chlorpramazine. British Journal of Psychiatry, 139, 112117.
Pugh, C. R., Steinart, J. & Priest, R. G. (1983) Propranolol in schizophrenia: a double blind, placebo controlled trial of propranolol as an adjunct to neuroleptic medication. British Journal of Psychiatry, 143, 151155.
Shanks, R. C. (1976) The properties of beta adrenoreceptor antagonists. Post Graduate Medical Journal. Supplement (4), 52, 1420.
Sheppard, G. P. (1979) High dose propranolol in schizophrenia. British Journal of Psychiatry, 134, 470476.
Wing, J. K., Cooper, J. E. & Sartorius, N. (1974) The Measurement and Classification of Psychiatric Symptoms. London: Cambridge University Press.
Yorkston, N. J., Zakl, S. A., Malik, M. K. U., Morrison, R. C. & Havard, C. W. H. (1974) Propranolol in the control of schizophrenic symptoms. British Medical Journal. 4, 633635.
Yorkston, N. J., Zakl, S. A., Theven, J. F. A., & Havard, C. W. H. (1976) Early observations on the effect of propranolol on psychotic patients. Advances in Clinical Pharmacology, 12, 91104.
Havard, C. W. H., Gruzelier, J. H., Zakl, S. A., Hollander, D., Pitcher, D. R. & Sergeant, H. G. (1977) Propranolol as an adjunct to the treatment of schizophrenia. The Lancet ii, 575578.
Hollander, D., Zakl, S. A., Weller, M. P., Gruzelier, J. H. & Hirsch, S. R. (1981) Dl-propranolol and chlorpromazine following admission for schizophrenia. A controlled comparison. Acta Psychiatrica Scandinavica, 63, 1327.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Does Propranolol have an Antipsychotic Effect?: A Placebo-Controlled Study in Acute Schizophrenia

  • Rahul Manchanda (a1) and Steven R. Hirsch (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *